Abstract
The occurrence of brain metastases in lung cancer affects the prognosis of patients. Following surgery, whole brain radiotherapy, stereotactic radiotherapy and chemotherapy, anti-angiogenesis therapy has become a new treatment option for lung cancer patients with brain metastases. As an anti-angiogenic drug, bevacizumab has a better effect of controlling peritumoral edema. Studies have shown that bevacizumab combined with chemotherapy, radiotherapy to treat non-small cell lung cancer with brain metastasis has a good efficacy and safety. Key words: Carcinoma, non-small-cell lung; Neoplasm metastases; Bevacizumab
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
